Contact Us Locations About Products Pipeline Partnering Patients Investors & News Careers About Us About Us Mission Leadership Transparency Reporting Clovis Oncology is on a Mission to Advance the Fight Against Cancer Founded in 2009, Clovis Oncology (NASDAQ: CLVS) is a commercial stage biotechnology company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets. Development Programs Are Focused on Providing the Right Drug, to the Right Patient at the Right Time Clovis’ product development programs generally target specific subsets of cancer, and the Company seeks to simultaneously develop, with partners, for those indications that require them, diagnostic tools intended to direct a compound in development to the patients most likely to benefit from their use. Through these collaborations, Clovis has the flexibility to choose the most appropriate technology for each program, and the expertise to gain regulatory approvals and support global commercialization that will parallel Clovis’ regulatory and commercialization paths. Clovis believes this approach to precision medicine—to deliver the right drug to the right patient at the right time—represents the future of cancer therapy. About Pipeline Patients Investors & News Careers Contact Us Privacy Policy Cookie Policy Terms Sitemap COPYRIGHT © 2021 BY CLOVIS ONCOLOGY, ALL RIGHTS RESERVED. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies, please see our Cookie Policy and Privacy Policy. By clicking Accept you consent to our use of cookies. Accept

Contact Us Locations About Products Pipeline Partnering Patients Investors & News Careers Transparency Reporting About Us Mission Leadership Transparency Reporting Transfers of Value to Healthcare Professionals (HCPs), Healthcare Organizations (HCOs) and Patient Organizations in Europe In line with local Transparency Reporting Requirements, Clovis Oncology is disclosing its interactions with Healthcare Professionals, Healthcare Organizations and Patient Organizations in the following countries. Inquiries should be directed here. Austria 2019 AUSTRIA TRANSPARENCY REPORT 2019 AUSTRIA METHODOLOGICAL NOTE 2020 AUSTRIA TRANSPARENCY REPORT 2020 AUSTRIA METHODOLOGICAL NOTE Germany 2019 GERMANY TRANSPARENCY REPORT 2019 GERMANY METHODOLOGICAL NOTE 2020 GERMANY TRANSPARENCY REPORT 2020 GERMANY METHODOLOGICAL NOTE About Pipeline Patients Investors & News Careers Contact Us Privacy Policy Cookie Policy Terms Sitemap COPYRIGHT © 2021 BY CLOVIS ONCOLOGY, ALL RIGHTS RESERVED. By using this website without changing your cookie settings, you agree to our use of cookies. For more information on how we use cookies, please see our Cookie Policy and Privacy Policy. By clicking Accept you consent to our use of cookies. Accept